Regeneron Pharmaceuticals Aktie

381,20EUR -3,20EUR -0,83%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 97,18
Fidelity Management & Research Co. LLC 10,34
The Vanguard Group, Inc. 7,56
Vanguard Group, Inc. (Subfiler) 7,12
Capital Research & Management Co. (World Investors) 6,62
State Street Corp. 4,47
BlackRock Fund Advisors 4,06
Wellington Management Co. LLP 3,46
American Funds Growth Fund of America 3,04
Loomis, Sayles & Co. LP 2,83
Vanguard Total Stock Market Index Fund 2,68
BlackRock Institutional Trust Co. NA 2,52
Vanguard Health Care Fund 2,44
Fidelity Contrafund 2,14
Vanguard 500 Index Fund 2,01

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2016 2017 2018 2019 2020
Personal am Ende des Jahres 5 400 6 200 7 400 8 100 9 123
Umsatz pro Mitarbeiter in Mio. EUR 0,90 0,95 0,91 0,97 0,93

Bilanz (in Mio. EUR) - Aktiva

2016 2017 2018 2019 2020
Summe Umlaufvermögen 3 180 4 335 6 448 7 689 9 779
Summe Anlagevermögen 4 928 6 848 9 466 11 804 13 721
Summe Aktiva 6 983 8 812 11 735 14 805 17 163

Bilanz (in Mio. EUR) - Passiva

2016 2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 479 703 709 714 2 696
Summe Fremdkapital 2 533 2 668 2 977 3 716 6 138
Summe Eigenkapital 4 449 6 144 8 757 11 090 11 025
Summe Passiva 6 983 8 812 11 735 14 805 17 163

Adresse

777 Old Saw Mill River Road, 10591-6707 Tarrytown
Telefon +1 (914) 847-7000
Internet http://www.regeneron.com

Management

Alan Shuldiner
Vice President-Translational Genetics
Andrew J. Murphy
Executive Vice President-Research
Arthur Frederick Ryan
Independent Director
Beth F. Levine
Chief Compliance Officer & Senior Vice President
Bob McCowan
Chief Information Officer & Senior VP-IT
Bonnie L. Bassler
Independent Director
Christine A. Poon
Independent Director
Christopher Robert Fenimore
Senior VP, Head-Accounting & Controller
Daniel P. Van Plew
EVP, GM-Industrial Operations & Product Supply
David Weinreich
Senior Vice President-Global Clinical Development
George Damis Yancopoulos
Co-President, Director & Chief Scientific Officer
George L. Sing
Independent Director
Gerald Underwood
Senior Vice President-Technical Operations
Huda Y. Zoghbi
Independent Director
Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Joseph L. Goldstein
Independent Director
Justin Holko
Head-Investor Relations
Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Leonard S. Schleifer
Co-President, Chief Executive Officer & Director
Marc Tessier-Lavigne
Independent Director
Marion McCourt
Senior Vice President & Commercial Head
Maya Bermingham
Senior VP, Public Policy & Government Affairs
Michael S. Brown
Independent Director
N. Anthony Coles
Independent Director
Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Neil Stahl
Executive VP-Research & Development
Nouhad Husseini
Vice President-Business Development
P. Roy Vagelos
Chairman
Patrice Gilooly
Senior VP-Quality Assurance & Operations
Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Sally A. Paull
Senior Vice President-Human Resources